| The prevalence of severe refractory asthma PPW Hekking, RR Wener, M Amelink, AH Zwinderman, ML Bouvy, EH Bel Journal of Allergy and Clinical Immunology 135 (4), 896-902, 2015 | 868 | 2015 |
| Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort DE Shaw, AR Sousa, SJ Fowler, LJ Fleming, G Roberts, J Corfield, ... European Respiratory Journal 46 (5), 1308-1321, 2015 | 622 | 2015 |
| U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics D Lefaudeux, B De Meulder, MJ Loza, N Peffer, A Rowe, F Baribaud, ... Journal of Allergy and Clinical Immunology 139 (6), 1797-1807, 2017 | 313 | 2017 |
| Developing and emerging clinical asthma phenotypes PPW Hekking, EH Bel The Journal of Allergy and Clinical Immunology: In Practice 2 (6), 671-680, 2014 | 148 | 2014 |
| Pathway discovery using transcriptomic profiles in adult-onset severe asthma PP Hekking, MJ Loza, S Pavlidis, B De Meulder, D Lefaudeux, F Baribaud, ... Journal of Allergy and Clinical Immunology 141 (4), 1280-1290, 2018 | 118 | 2018 |
| Comorbidities in difficult-to-control asthma PP Hekking, M Amelink, RR Wener, ML Bouvy, EH Bel The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 108-113, 2018 | 98 | 2018 |
| Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma P Brinkman, AH Wagener, PP Hekking, AT Bansal, ... Journal of Allergy and Clinical Immunology 143 (5), 1811-1820. e7, 2019 | 96 | 2019 |
| Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma PP Hekking, MJ Loza, S Pavlidis, B De Meulder, D Lefaudeux, F Baribaud, ... European Respiratory Journal 50 (3), 2017 | 53 | 2017 |
| Treatable traits in the European U‐BIOPRED adult asthma cohorts AJ Simpson, PP Hekking, DE Shaw, LJ Fleming, G Roberts, JH Riley, ... Allergy 74 (2), 406, 2018 | 50 | 2018 |
| Overuse of oral corticosteroids, underuse of inhaled corticosteroids, and implications for biologic therapy in asthma K Eger, M Amelink, S Hashimoto, PP Hekking, C Longo, EH Bel Respiration 101 (2), 116-121, 2022 | 16 | 2022 |
| Chest computed tomography and alveolar–arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients MP de Roos, ID Kilsdonk, PPW Hekking, J Peringa, NG Dijkstra, ... ERJ open research 7 (1), 2021 | 11 | 2021 |
| Peripheral infiltration of remdesivir in 3 patients with COVID-19: Case series and discussion LN van Merendonk, AF Leeuwerik, MWJ den Brok, PPW Hekking, ... American Journal of Health-System Pharmacy 78 (21), 1944-1951, 2021 | 6 | 2021 |
| Anti-IL-5/5Ra biologics improve work productivity and activity in severe asthma: a RAPSODI registry-based cohort study JPM van der Valk, PP Hekking, SP Rauh, KW Patberg, IA van Veen, ... Journal of Asthma 60 (10), 1869-1876, 2023 | 5 | 2023 |
| Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma. PP Hekking, K Zhang, CPV Garrido, R Lopez-Rodriguez, M Kjarsgaard, ... Authorea Preprints, 2023 | 4 | 2023 |
| Late Breaking Abstract-Overuse of oral corticosteroids in asthma–modifiable factors and potential role of biologics KAB Eger, M Amelink, PP Hekking, E Bel European Respiratory Journal 54 (suppl 63), 2019 | 4 | 2019 |
| eTRIKS IT platfroms for large-scale biomedical research I Pandis, Y Guo, F Guitton, X Yang, K Sun, S Wang, N Jullian, AR Sousa, ... European Respiratory Journal 46 (suppl 59), 2015 | 3 | 2015 |
| Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome PP Hekking, M Amelink, RR Wener, ML Bouvy, EH Bel European Respiratory Journal 46 (suppl 59), 2015 | 3 | 2015 |
| Unbiased clustering of severe asthma patients based on exhaled breath profiles P Brinkman, PP Hekking, S Hashimoto, Y Wang, A Vink, H Weda, ... European Respiratory Journal 46 (suppl 59), 2015 | 2 | 2015 |
| Severe COPD: Multidisciplinary Consultation to Get the Right Care at the Right Place PP Hekking, M van Meggelen, WJ Lie, RAS Hoek, D van Ranst, ... International Journal of Chronic Obstructive Pulmonary Disease, 749-752, 2024 | 1 | 2024 |
| Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti–IL-5 Therapies in Severe Asthma PP Hekking, WG Teague The Journal of Allergy and Clinical Immunology: In Practice 7 (8), 2697-2698, 2019 | 1 | 2019 |
